Albany, NY -- (SBWIRE) -- 11/19/2015 -- The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent expirations of the key blockbuster revenue generating drugs such as Cymbalta (duloxetine) of Eli Lilly & Co. and Lyrica (pregabalin) of Pfizer, Inc. This report studies the global market for pain management therapeutics from three perspectives - therapeutic classes of drugs, indications and geography. Each of these segments is further classified into sub-segments; therapeutic classes include anticonvulsants, antidepressants, anesthetics, NSAIDs, opioids, anti-migraine agents and other non-narcotic analgesics.

Complete Report with TOC @ http://www.mrrse.com/pain-management-therapeutics

The various pain management indications studied in this report include neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain and cancer pain. Market sizes and forecasts for the period 2010 – 2018 have been provided for each of the segments and sub-segments in terms of USD million, considering 2011 as the base year. The % compound annual growth rate (CAGR) for each market segment for the forecast period (2012 to 2018) has been provided along with market size estimations.

Geographically, the market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The respective market sizes and forecasts have been provided for each of these regions along with the CAGR. The market overview section of the report provides a detailed breakdown of various aspects of market dynamics such as drivers, restraints and opportunities along with market attractiveness analysis and Porter's five force analysis for the pain management therapeutics market.

Inquiry on this report @ http://www.mrrse.com/enquiry/870

The competitive landscape section includes market share analysis of all the leading players in the branded pharmaceuticals market for pain management, in terms of percentage share in the year 2011. Some of the major players profiled in this report include Abbott Laboratories, Inc., AstraZeneca PLC, Eli Lilly & Co., Endo Health Solutions, Johnson & Johnson, Merck & Co., Inc., Pfizer, Inc. and Purdue Pharma LP.

The global pain management market is segmented into the following categories:

Pain Management Therapeutics Market, by Therapeutic Class

Anticonvulsants
Antidepressants
Anesthetics
NSAIDs
Opioids
Other Non-Narcotic Analgesics (Acetaminophen)
Anti-Migraine Agents

Request a Sample Copy of the Report @ http://www.mrrse.com/sample/870

About MRRSE
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.